title: A case of long-term remission with ofatumumab maintenance therapy in multiply relapsed and rituximab-refractory chronic lymphocytic leukaemia with deletion 17p.
authors.forename: Konrad
authors.initials: K
authors.lastname: Namberger
authors.forename: Lukas
authors.initials: L
authors.lastname: Weiss
authors.forename: Barbara
authors.initials: B
authors.lastname: Krause
authors.forename: Thomas
authors.initials: T
authors.lastname: Melchardt
authors.forename: Richard
authors.initials: R
authors.lastname: Greil
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002872:Chromosome Deletion; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics* / Q000628:therapy*; D060046:Maintenance Chemotherapy; D008297:Male; D012008:Recurrence; D012074:Remission Induction; D000069283:Rituximab; D058496:Smith-Magenis Syndrome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab; C527517:ofatumumab